{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:17:18Z","timestamp":1790713038977,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL107326"],"award-info":[{"award-number":["HL107326"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["IRTG1902"],"award-info":[{"award-number":["IRTG1902"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvascsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.jvs.2018.11.045","type":"journal-article","created":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T21:38:51Z","timestamp":1551821931000},"page":"1658-1668.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Mas receptor deficiency augments angiotensin II-induced atherosclerosis and aortic aneurysm ruptures in hypercholesterolemic male mice"],"prefix":"10.1016","volume":"70","author":[{"given":"Johannes","family":"Stegbauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean E.","family":"Thatcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Bottermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Christian","family":"Rump","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Daugherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Cassis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2018.11.045_bib1","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1172\/JCI7818","article-title":"Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice","volume":"105","author":"Daugherty","year":"2000","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jvs.2018.11.045_bib2","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1161\/01.ATV.0000254680.71485.92","article-title":"Bone marrow transplantation reveals that recipient AT1a receptors are required to initiate angiotensin II-induced atherosclerosis and aneurysms","volume":"27","author":"Cassis","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jvs.2018.11.045_bib3","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1111\/j.1476-5381.2011.01712.x","article-title":"Comparative effects of different modes of renin angiotensin system inhibition on hypercholesterolaemia-induced atherosclerosis","volume":"165","author":"Lu","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jvs.2018.11.045_bib4","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/00005344-199804000-00011","article-title":"Antiatherosclerotic and antioxidative effects of captopril in apolipoprotein E-deficient mice","volume":"31","author":"Hayek","year":"1998","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.jvs.2018.11.045_bib5","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Yusuf","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2018.11.045_bib6","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(06)69250-7","article-title":"Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study","volume":"368","author":"Hackam","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2018.11.045_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jvs.2010.02.264","article-title":"Use of angiotensin converting enzyme inhibitors is associated with increased growth rate of abdominal aortic aneurysms","volume":"52","author":"Sweeting","year":"2010","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2018.11.045_bib8","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1161\/ATVBAHA.114.304428","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with abdominal aortic aneurysms: nation-wide cohort study","volume":"35","author":"Kristensen","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jvs.2018.11.045_bib9","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/bjs.9895","article-title":"Multicentre study of abdominal aortic aneurysm measurement and enlargement","volume":"102","author":"Lederle","year":"2015","journal-title":"Br J Surg"},{"key":"10.1016\/j.jvs.2018.11.045_bib10","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas","volume":"100","author":"Santos","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jvs.2018.11.045_bib11","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A\u00a0human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase","volume":"275","author":"Tipnis","year":"2000","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jvs.2018.11.045_bib12","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A\u00a0novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.jvs.2018.11.045_bib13","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1161\/ATVBAHA.114.304613","article-title":"Angiotensin-converting enzyme 2 decreases formation and severity of angiotensin II-induced abdominal aortic aneurysms","volume":"34","author":"Thatcher","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jvs.2018.11.045_bib14","doi-asserted-by":"crossref","unstructured":"Hao Q, Dong X, Chen X, Yan F, Wang X, Shi H, et al. Angiotensin-converting enzyme 2 inhibits angiotensin II-induced abdominal aortic aneurysm in mice [published online ahead of print November 13, 2018]. Hum Gene Ther doi: 10.1089\/hum.2016.144.","DOI":"10.1089\/hum.2016.144"},{"key":"10.1016\/j.jvs.2018.11.045_bib15","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1161\/ATVBAHA.110.221614","article-title":"Angiotensin-converting enzyme 2 deficiency in whole body or bone marrow-derived cells increases atherosclerosis in low-density lipoprotein receptor\u2212\/\u2212 mice","volume":"31","author":"Thatcher","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jvs.2018.11.045_bib16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/335437a0","article-title":"The mas oncogene encodes an angiotensin receptor","volume":"335","author":"Jackson","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.jvs.2018.11.045_bib17","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/j.1476-5381.2011.01295.x","article-title":"Chronic treatment with angiotensin-(1-7) improves renal endothelial dysfunction in apolipoproteinE-deficient mice","volume":"163","author":"Stegbauer","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jvs.2018.11.045_bib18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/HYPERTENSIONAHA.113.02289","article-title":"Angiotensin-(1-7) modulates renal vascular resistance through inhibition of p38 mitogen-activated protein kinase in apolipoprotein E-deficient mice","volume":"63","author":"Potthoff","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.jvs.2018.11.045_bib19","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1161\/HYPERTENSIONAHA.107.102764","article-title":"Endothelial dysfunction and elevated blood pressure in MAS gene-deleted mice","volume":"51","author":"Xu","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.jvs.2018.11.045_bib20","doi-asserted-by":"crossref","first-page":"e92720","DOI":"10.1172\/jci.insight.92720","article-title":"Resistance to hypertension mediated by intercalated cells of the collecting duct","volume":"2","author":"Stegbauer","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.jvs.2018.11.045_bib21","first-page":"293","article-title":"Quantification of atherosclerosis in mice","volume":"209","author":"Daugherty","year":"2003","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jvs.2018.11.045_bib22","doi-asserted-by":"crossref","first-page":"H459","DOI":"10.1152\/ajpheart.00498.2016","article-title":"Differential effects of Mas receptor deficiency on cardiac function and blood pressure in obese male and female mice","volume":"312","author":"Wang","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jvs.2018.11.045_bib23","article-title":"Increased vascular sympathetic modulation in mice with Mas receptor deficiency","volume":"17","author":"Rabello Casali","year":"2016","journal-title":"J\u00a0Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.jvs.2018.11.045_bib24","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1172\/JCI16980","article-title":"Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice","volume":"116","author":"Gurley","year":"2006","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jvs.2018.11.045_bib25","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nature00786","article-title":"Angiotensin-converting enzyme 2 is an essential regulator of heart function","volume":"417","author":"Crackower","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jvs.2018.11.045_bib26","first-page":"984","article-title":"Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice","volume":"118","author":"Lu","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jvs.2018.11.045_bib27","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1161\/01.CIR.0000150540.54220.C4","article-title":"Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor","volume":"110","author":"Daugherty","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2018.11.045_bib28","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1161\/CIRCRESAHA.110.219279","article-title":"Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse","volume":"107","author":"Thomas","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.jvs.2018.11.045_bib29","doi-asserted-by":"crossref","first-page":"H1377","DOI":"10.1152\/ajpheart.00331.2008","article-title":"Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis","volume":"295","author":"Lovren","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jvs.2018.11.045_bib30","doi-asserted-by":"crossref","first-page":"15886","DOI":"10.1073\/pnas.1001253107","article-title":"Angiotensin-converting enzyme 2 attenuates atherosclerotic lesions by targeting vascular cells","volume":"107","author":"Zhang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jvs.2018.11.045_bib31","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/ATVBAHA.110.204453","article-title":"Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice","volume":"30","author":"Tesanovic","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jvs.2018.11.045_bib32","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00424-018-2108-1","article-title":"Angiotensin-(1-7)-induced Mas receptor activation attenuates atherosclerosis through a nitric oxide-dependent mechanism in apolipoproteinE-KO mice","volume":"470","author":"Yang","year":"2018","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.jvs.2018.11.045_bib33","doi-asserted-by":"crossref","first-page":"14109","DOI":"10.1073\/pnas.1612668113","article-title":"Role of the receptor Mas in macrophage-mediated inflammation in\u00a0vivo","volume":"113","author":"Hammer","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jvs.2018.11.045_bib34","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1172\/JCI8931","article-title":"Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms","volume":"105","author":"Pyo","year":"2000","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jvs.2018.11.045_bib35","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jvs.2006.01.004","article-title":"Temporal changes in mouse aortic wall gene expression during the development of elastase-induced abdominal aortic aneurysms","volume":"43","author":"Van Vickle-Chavez","year":"2006","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2018.11.045_bib36","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/1471-2164-10-298","article-title":"Whole genome expression analysis within the angiotensin II-apolipoprotein E deficient mouse model of abdominal aortic aneurysm","volume":"10","author":"Rush","year":"2009","journal-title":"BMC Genomics"},{"key":"10.1016\/j.jvs.2018.11.045_bib37","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1002\/jcp.22940","article-title":"Angiotensin-(1-7) decreases LPS-induced inflammatory response in macrophages","volume":"227","author":"Souza","year":"2012","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.jvs.2018.11.045_bib38","first-page":"77","article-title":"Angiotensin-(1-7) receptor Mas agonist ameliorates progress of atherosclerosis in apoE-knockout mice","volume":"63","author":"Jawien","year":"2012","journal-title":"J\u00a0Physiol Pharmacol"},{"key":"10.1016\/j.jvs.2018.11.045_bib39","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1111\/bph.13685","article-title":"Anti-atherosclerotic effect of the angiotensin 1-7 mimetic AVE0991 is mediated by inhibition of perivascular and plaque inflammation in early atherosclerosis","volume":"174","author":"Skiba","year":"2017","journal-title":"Br J Pharmacol"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521419301272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521419301272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:25:13Z","timestamp":1760041513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521419301272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0741521419301272"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2018.11.045","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mas receptor deficiency augments angiotensin II-induced atherosclerosis and aortic aneurysm ruptures in hypercholesterolemic male mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2018.11.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc. on behalf of the Society for Vascular Surgery.","name":"copyright","label":"Copyright"}]}}